Xponance Inc. Reduces Holdings in Chemed Co. (NYSE:CHE)

Xponance Inc. trimmed its holdings in shares of Chemed Co. (NYSE:CHE) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,943 shares of the company’s stock after selling 31 shares during the period. Xponance Inc.’s holdings in Chemed were worth $1,721,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of CHE. SG Americas Securities LLC increased its stake in shares of Chemed by 32.8% during the 3rd quarter. SG Americas Securities LLC now owns 3,290 shares of the company’s stock worth $1,710,000 after purchasing an additional 813 shares in the last quarter. BTC Capital Management Inc. grew its stake in Chemed by 7.9% in the 3rd quarter. BTC Capital Management Inc. now owns 834 shares of the company’s stock worth $433,000 after acquiring an additional 61 shares during the period. Boston Trust Walden Corp grew its stake in Chemed by 3.8% in the 3rd quarter. Boston Trust Walden Corp now owns 216,337 shares of the company’s stock worth $112,430,000 after acquiring an additional 7,968 shares during the period. Golden State Equity Partners grew its stake in Chemed by 29.4% in the 3rd quarter. Golden State Equity Partners now owns 673 shares of the company’s stock worth $350,000 after acquiring an additional 153 shares during the period. Finally, Trinity Street Asset Management LLP grew its stake in Chemed by 3.0% in the 3rd quarter. Trinity Street Asset Management LLP now owns 29,861 shares of the company’s stock worth $15,519,000 after acquiring an additional 863 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Chemed Stock Up 2.0 %

Shares of NYSE CHE opened at $616.51 on Wednesday. Chemed Co. has a 52-week low of $492.84 and a 52-week high of $654.62. The firm has a fifty day moving average of $622.33 and a 200-day moving average of $589.76. The stock has a market capitalization of $9.32 billion, a PE ratio of 34.40, a P/E/G ratio of 2.41 and a beta of 0.42.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, February 27th. The company reported $6.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.25 by $0.35. Chemed had a net margin of 12.03% and a return on equity of 32.29%. The company had revenue of $585.90 million during the quarter, compared to analysts’ expectations of $586.64 million. During the same period in the previous year, the company earned $5.39 EPS. The business’s quarterly revenue was up 7.2% compared to the same quarter last year. Equities research analysts expect that Chemed Co. will post 21.99 EPS for the current fiscal year.

Chemed Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 15th. Stockholders of record on Monday, February 26th were paid a dividend of $0.40 per share. The ex-dividend date was Friday, February 23rd. This represents a $1.60 annualized dividend and a dividend yield of 0.26%. Chemed’s dividend payout ratio is presently 8.93%.

Analyst Upgrades and Downgrades

Several research firms have commented on CHE. Royal Bank of Canada lifted their target price on shares of Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a research note on Monday, March 4th. Oppenheimer lifted their target price on shares of Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Thursday, February 29th.

Insider Activity

In related news, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the transaction, the executive vice president now owns 20,760 shares in the company, valued at approximately $13,320,654. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, EVP Spencer S. Lee sold 2,000 shares of Chemed stock in a transaction on Thursday, March 28th. The shares were sold at an average price of $641.65, for a total transaction of $1,283,300.00. Following the transaction, the executive vice president now owns 20,760 shares in the company, valued at approximately $13,320,654. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, VP Brian C. Judkins sold 11,158 shares of Chemed stock in a transaction on Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the transaction, the vice president now owns 1,422 shares in the company, valued at approximately $917,190. The disclosure for this sale can be found here. Insiders sold 15,808 shares of company stock valued at $10,184,531 in the last ninety days. Company insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.